Lafayette Investments’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$20.5K	Hold	13,000	–	–	﹤0.01%	157
2025 Q4	$21.7K	Hold	13,000	–	–	﹤0.01%	156
2025 Q3	$22K	Hold	13,000	–	–	﹤0.01%	155
2025 Q2	$11.8K	Hold	13,000	–	–	﹤0.01%	150
2025 Q1	$5.87K	Hold	13,000	–	–	﹤0.01%	146
2024 Q4	$6.53K	Hold	13,000	–	–	﹤0.01%	149
2024 Q3	$11.8K	Hold	13,000	–	–	﹤0.01%	146
2024 Q2	$13K	Hold	13,000	–	–	﹤0.01%	142
2024 Q1	$19.2K	Hold	13,000	–	–	﹤0.01%	141
2023 Q4	$14.2K	Hold	13,000	–	–	﹤0.01%	135
2023 Q3	$15.3K	Hold	13,000	–	–	﹤0.01%	128
2023 Q2	$18.3K	Hold	13,000	–	–	﹤0.01%	126
2023 Q1	$19.5K	Hold	13,000	–	–	0.01%	124
2022 Q4	$15.2K	Hold	13,000	–	–	﹤0.01%	121
2022 Q3	$15K	Hold	13,000	–	–	﹤0.01%	117
2022 Q2	$21K	Hold	13,000	–	–	0.01%	120
2022 Q1	$20K	Hold	13,000	–	–	0.01%	128
2021 Q4	$32K	Hold	13,000	–	–	0.01%	125
2021 Q3	$33K	Hold	13,000	–	–	0.01%	125
2021 Q2	$37K	Hold	13,000	–	–	0.01%	124
2021 Q1	$31K	Buy	13,000 +3,000	+30%	+$7.2K	0.01%	90
2020 Q4	$18K	Buy	+10,000	New	+$14K	0.01%	87

Other funds holding LCTX